As of 2026-09-10, the Relative Valuation of Syndax Pharmaceuticals Inc (SNDX) is (68.02) USD. This relative valuation is based on P/E multiples. With the latest stock price at 19.84 USD, the upside of Syndax Pharmaceuticals Inc based on Relative Valuation is -442.8%.
The range of the Relative Valuation is (60.54) - (74.74) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.2x - 30.0x | 27.1x |
| Forward P/E multiples | 24.3x - 30.7x | 27.5x |
| Fair Price | (60.54) - (74.74) | (68.02) |
| Upside | -405.1% - -476.7% | -442.8% |
| Date | P/E |
| 2026-09-09 | -8.11 |
| 2026-09-08 | -8.00 |
| 2026-09-04 | -8.25 |
| 2026-09-03 | -8.30 |
| 2026-09-02 | -8.34 |
| 2026-09-01 | -8.07 |
| 2026-08-31 | -7.74 |
| 2026-08-28 | -7.84 |
| 2026-08-27 | -8.09 |
| 2026-08-26 | -8.06 |
| 2026-08-25 | -8.00 |
| 2026-08-24 | -7.85 |
| 2026-08-21 | -7.89 |
| 2026-08-20 | -7.93 |
| 2026-08-19 | -8.34 |
| 2026-08-18 | -7.99 |
| 2026-08-17 | -7.93 |
| 2026-08-14 | -7.96 |
| 2026-08-13 | -7.66 |
| 2026-08-12 | -7.95 |
| 2026-08-11 | -8.14 |
| 2026-08-10 | -8.18 |
| 2026-08-07 | -8.19 |
| 2026-08-06 | -7.93 |
| 2026-08-05 | -8.00 |
| 2026-08-04 | -7.66 |
| 2026-08-03 | -7.72 |
| 2026-07-31 | -7.65 |
| 2026-07-30 | -7.82 |
| 2026-07-29 | -7.71 |
| 2026-07-28 | -7.88 |
| 2026-07-27 | -8.24 |
| 2026-07-24 | -8.35 |
| 2026-07-23 | -8.51 |
| 2026-07-22 | -8.85 |
| 2026-07-21 | -9.09 |
| 2026-07-20 | -8.95 |
| 2026-07-17 | -9.15 |
| 2026-07-16 | -9.12 |
| 2026-07-15 | -9.44 |
| 2026-07-14 | -9.69 |
| 2026-07-13 | -9.19 |
| 2026-07-10 | -9.48 |
| 2026-07-09 | -9.97 |
| 2026-07-08 | -9.86 |
| 2026-07-07 | -9.33 |
| 2026-07-06 | -8.86 |
| 2026-07-02 | -8.76 |
| 2026-07-01 | -8.38 |
| 2026-06-30 | -8.77 |